Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy

By Criscitiello Carmen   Gelao Lucia   Viale Giulia   Esposito Angela   Curigliano Giuseppe  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 599-610

Informa Healthcare

Access to resources Recommend Favorite

Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non-small Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 107-123

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting malignant glioma cells in vitro using platelet-derived growth factor AA-based conjugates

By Wester Maria Dahlstrom   Wasteson Åke   Lindstrom Annelie  

Journal of Drug Targeting, Vol. 17, Iss. 4, 2009-05 ,pp. : 268-277

Informa Healthcare

Access to resources Recommend Favorite

Tyr⁷⁴⁰ and Tyr⁷⁵¹ residues of platelet-derived growth factor beta receptor are responsible for the redox regulation of phosphatase and tensin homolog in the cells stimulated with platelet-derived growth factor

By Kim Inyoung   Han Seong-Jeong   Kim Yujeong   Ahn Younghee   Chay Kee-Oh   Lee Seung-Rock  

Redox Report, Vol. 16, Iss. 4, 2011-07 ,pp. : 181-186

Maney Publishing

Access to resources Recommend Favorite

Pyrrolo[3,4-c]- -carboline-diones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase

By Teller S.   Eluwa S.   Koller M.   Uecker A.   Beckers T.   Baasner S.   Bohmer F.-D.   Mahboobi S.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 4, 2000-04 ,pp. : 413-427

Elsevier

Access to resources Recommend Favorite